GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (NAS:NBIX) » Definitions » E10

NBIX (Neurocrine Biosciences) E10 : $0.87 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Neurocrine Biosciences's adjusted earnings per share data for the three months ended in Mar. 2025 was $0.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.87 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Neurocrine Biosciences's average E10 Growth Rate was 85.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Neurocrine Biosciences was 56.20% per year. The lowest was -23.60% per year. And the median was 9.30% per year.

As of today (2025-07-09), Neurocrine Biosciences's current stock price is $128.74. Neurocrine Biosciences's E10 for the quarter that ended in Mar. 2025 was $0.87. Neurocrine Biosciences's Shiller PE Ratio of today is 147.98.

During the past 13 years, the highest Shiller PE Ratio of Neurocrine Biosciences was 10477.00. The lowest was 104.45. And the median was 301.06.


Neurocrine Biosciences E10 Historical Data

The historical data trend for Neurocrine Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences E10 Chart

Neurocrine Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.07 0.07 0.40 0.85

Neurocrine Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.56 0.72 0.85 0.87

Competitive Comparison of Neurocrine Biosciences's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Neurocrine Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurocrine Biosciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurocrine Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Neurocrine Biosciences's Shiller PE Ratio falls into.


;
;

Neurocrine Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neurocrine Biosciences's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.08/134.9266*134.9266
=0.080

Current CPI (Mar. 2025) = 134.9266.

Neurocrine Biosciences Quarterly Data

per share eps CPI Adj_EPS
201506 -0.280 100.684 -0.375
201509 -0.400 100.392 -0.538
201512 -0.340 99.792 -0.460
201603 -0.220 100.470 -0.295
201606 -0.460 101.688 -0.610
201609 -0.430 101.861 -0.570
201612 -0.510 101.863 -0.676
201703 -0.900 102.862 -1.181
201706 -0.680 103.349 -0.888
201709 -0.130 104.136 -0.168
201712 0.070 104.011 0.091
201803 -0.470 105.290 -0.602
201806 -0.070 106.317 -0.089
201809 0.520 106.507 0.659
201812 0.190 105.998 0.242
201903 -1.120 107.251 -1.409
201906 0.540 108.070 0.674
201909 0.560 108.329 0.697
201912 0.350 108.420 0.436
202003 0.390 108.902 0.483
202006 0.810 108.767 1.005
202009 -0.620 109.815 -0.762
202012 3.580 109.897 4.395
202103 0.330 111.754 0.398
202106 0.430 114.631 0.506
202109 0.230 115.734 0.268
202112 -0.080 117.630 -0.092
202203 0.140 121.301 0.156
202206 -0.180 125.017 -0.194
202209 0.690 125.227 0.743
202212 0.880 125.222 0.948
202303 -0.790 127.348 -0.837
202306 0.950 128.729 0.996
202309 0.820 129.860 0.852
202312 1.440 129.419 1.501
202403 0.420 131.776 0.430
202406 0.630 132.554 0.641
202409 1.240 133.029 1.258
202412 1.000 133.157 1.013
202503 0.080 134.927 0.080

Add all the adjusted EPS together and divide 10 will get our e10.


Neurocrine Biosciences  (NAS:NBIX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Neurocrine Biosciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=128.74/0.87
=147.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Neurocrine Biosciences was 10477.00. The lowest was 104.45. And the median was 301.06.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Neurocrine Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurocrine Biosciences Business Description

Address
6027 Edgewood Bend Court, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Executives
Kevin Charles Gorman officer: Sr VP, Business Development 12790 EL CAMINO REAL, SAN DIEGO CA 92130
William H Rastetter director 9885 TOWNE CENTRE DR., SAN DIEGO CA 92121
Eiry Roberts officer: Chief Medical Officer C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEO CA 92130
Stephen A Sherwin director C/O CELL GENESYS, INC., 500 FORBES BLVD., SOUTH SAN FRANCISCO CA 94080
Ingrid Delaet officer: Chief Regulatory Officer C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130
Jude Onyia officer: Chief Scientific Officer C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130
David W. Boyer officer: Chief Corp. Affairs Officer C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130
Matt Abernethy officer: Chief Financial Officer C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92121
Eric Benevich officer: Chief Commerical Officer C/O NEUROCRINE BIOSCIENCES, INC., 12790 EL CAMINO REAL, SAN DIEGO CA 92130
Kyle Gano officer: Chief Business Dev Officer NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130
Darin Lippoldt officer: Chief Legal Officer C/O VOLCANO CORPORATION, 3661 VALLEY CENTRE DRIVE, SUITE 200, SAN DIEGO CA 92130
Julie Cooke officer: Chief Human Resources Officer C/O NEUROCRINE BIOSCIENCES, INC., 12780 EL CAMINO REAL, SAN DIEGO CA 92130
Gary A Lyons director, officer: President and CEO 12790 EL CAMINO REAL, C/O NEUROCRINE BIOSCIENCES, SAN DIEGO CA 92130
Shalini Sharp director C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO CA 94949
Richard F Pops director 10555 SCIENCE CENTER DR, SAN DIEGO CA 92121

Neurocrine Biosciences Headlines

From GuruFocus